Calendar Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse 01:30:02 20/07/2024 am IST 5-day change 1st Jan Change
125.8 USD +1.22% Intraday chart for Merck & Co., Inc. -1.56% +15.36%

Chart calendar Merck & Co., Inc.

2b10cdc217bc864231f670a5b.WIk4WZAzh4BawL6c90BeBgVMo8YYzt_8foH_ciVwdO8.FMZKDd1Jw8MZo8jaxyRoQUp7kJFIlLiwMvKWFhBIRaF10Ggyw1XRywKmig~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

23/07/2024 09:30 pm International AIDS Conference
24/07/2024 03:30 pm International AIDS Conference
30/07/2024 04:00 pm Q2 2024 Earnings Release
30/07/2024 06:30 pm Q2 2024 Earnings Call
31/10/2024 04:00 pm Q3 2024 Earnings Release
31/10/2024 06:30 pm Q3 2024 Earnings Call
30/01/2025 Q4 2024 Earnings Release (Projected)
24/04/2025 Q1 2025 Earnings Release (Projected)
05/08/2025 Q2 2025 Earnings Release (Projected)
23/10/2025 Q3 2025 Earnings Release (Projected)

Past events on Merck & Co., Inc.

17/06/2024 Détachement de
11/06/2024 07:30 pm Goldman Sachs Global Healthcare Conference
04/06/2024 04:30 am American Society of Clinical Oncology Meeting
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 8012
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 9559
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 8502
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 4093
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 5502
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: LBA4132
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 4100
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 4502
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 4045
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 9554
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: LBA9512
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 104
28/05/2024 06:30 pm Annual General Meeting
16/05/2024 02:10 am BofA Securities Health Care Conference
25/04/2024 06:30 pm Q1 2024 Earnings Call
25/04/2024 04:00 pm Q1 2024 Earnings Release
14/03/2024 Détachement de

Past dividends on Merck & Co., Inc.

17/06/2024 Quarterly 0.77 USD
14/03/2024 Quarterly 0.77 USD
14/12/2023 Quarterly 0.77 USD
14/09/2023 Quarterly 0.73 USD
14/06/2023 Quarterly 0.73 USD
14/03/2023 Quarterly 0.73 USD
14/12/2022 Quarterly 0.73 USD
14/09/2022 Quarterly 0.69 USD
14/06/2022 Quarterly 0.69 USD
14/03/2022 Quarterly 0.69 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
46 840
46 818
0.05%
47 994
48 177
-0.38%
48 704
48 367
0.7%
59 283
59 144
0.24%
60 115
59 938
0.3%

64 238

EBITDA
Million USD
Released
Forecast
Spread
19 572
18 761
4.32%
20 570
19 815
3.81%
20 910
19 760
5.82%
26 431
24 588
7.5%
10 083
9 362
7.71%

28 552

EBIT
Million USD
Released
Forecast
Spread
15 920
16 276
-2.19%
16 945
17 366
-2.43%
17 696
17 554
0.81%
22 522
22 363
0.71%
6 211
6 066
2.4%

25 733

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
11 464
12 277
-6.62%
8 791
14 906
-41.02%
13 879
12 048
15.2%
16 444
17 389
-5.44%
1 889
2 857
-33.89%

24 025

Net income
Million USD
Released
Forecast
Spread
9 843
9 957
-1.15%
7 067
12 094
-41.57%
13 049
11 797
10.61%
14 519
14 827
-2.07%
365
1 682
-78.3%

19 510

EPS
USD
Released
Forecast
Spread
3,81
3,83
-0.52%
2,78
4,71
-41%
5,14
4,70
9.39%
5,71
5,87
-2.73%
0,14
0,56
-75.16%

7,75

Announcement Date05/02/2004/02/2103/02/2202/02/2301/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
15 901
14 648
8.55%
14 593
13 861
5.28%
14 959
14 043
6.52%
13 830
13 676
1.12%
14 487
13 799
4.98%
15 035
14 450
4.05%
15 962
15 273
4.51%
14 630
14 480
1.03%
15 775
15 204
3.75%

15 822


16 668


15 969


16 745


17 483

EBITDA
Million USD
Released
Forecast
Spread
7 568
5 918
27.88%
6 649
6 064
9.65%
6 516
6 275
3.85%
5 698
5 183
9.94%
5 402
5 058
6.8%
-3 485
-3 901
10.67%
7 538
6 724
12.1%
665
1 985
-66.49%
7 367
6 562
12.27%

7 367


7 236


7 639







EBIT
Million USD
Released
Forecast
Spread
6 448
5 393
19.56%
5 711
5 157
10.75%
5 557
5 268
5.49%
4 806
4 592
4.66%
4 411
4 088
7.89%
-4 388
-4 683
6.29%
6 524
5 967
9.33%
-299
-476
37.23%
6 383
5 808
9.91%

6 499


6 278


6 282







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread






3 583
3 956
-9.43%
3 513
3 391
3.6%
3 650
4 190
-12.89%
-5 335
-4 682
-13.95%
5 620
5 023
11.89%
-2 046
-1 249
-63.78%
5 670
5 267
7.66%

6 023


5 754


5 700







Net income
Million USD
Released
Forecast
Spread
4 310
3 768
14.4%
3 944
3 859
2.19%
3 248
3 477
-6.6%
3 017
3 016
0.02%
2 821
3 133
-9.97%
-5 975
-6 154
2.9%
4 745
4 224
12.34%
-1 226
-919
-33.43%
4 762
4 414
7.88%

4 942


4 599


4 773







EPS
USD
Released
Forecast
Spread
1,70
1,48
14.96%
1,55
1,48
4.46%
1,28
1,42
-10.11%
1,18
1,20
-1.99%
1,11
1,21
-8.14%
-2,35
-2,44
3.61%
1,86
1,65
12.59%
-0,48
-0,35
-37.91%
1,87
1,79
4.45%

1,93


1,93


1,95







Announcement Date28/04/2228/07/2227/10/2202/02/2327/04/2301/08/2326/10/2301/02/2425/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Calendar Merck & Co., Inc.